Abstract
Recent results from the ACOSOG Z0011 trial question the use of intraoperative frozen section (FS) during sentinel lymph node (SLN) biopsy and the role of axillary dissection (ALND) for SLN-positive breast cancer patients. Here we present a 10-year trend analysis of SLN-FS and ALND in our practice. We reviewed our prospective SLN database over 10years (1997-2006, 7509 SLN procedures) for time trends and variation between surgeons in the use of SLN-FS and ALND in patients with cN0 invasive breast cancer. Use of SLN-FS decreased from 100% to 62% (P<0.0001) and varied widely by surgeon (66% to 95%). There were no statistically significant trends in the performance of ALND for patients with SLN metastases detected by FS (n=1370, 99-99%) or routine hematoxylin and eosin (H&E) (n=333; 69-77%), but only for those detected by serial section H&E with or without immunohistochemistry (n=438; 73-48%; P=0.0054) or immunohistochemistry only (n=294; 48-28%; P<0.0001). These trends coincided with an increase in the proportion of completion versus immediate ALND (30-40%; P=0.0710). Over 10years, we have observed a diminishing rate of SLN-FS and, for patients with low-volume SLN metastases, fewer ALND, trends that suggest a more nuanced approach to axillary management. If the Z0011 selection criteria had been applied to our cohort, 66% of SLN-FS (4159 of 6327) and 48% of ALND (939 of 1953) would have been avoided, sparing 13% of all patients the morbidity of ALND.
Accepted Version (
Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call